BD stock slides amid earnings report, business split update
Becton Dickinson (BDX) stock slid 3% after the company released its fiscal Q1 earnings report and confirmed it was splitting the company into two separate entities.
BD Stock Falls in Pre-Market Despite Q1 Earnings Beat, Gross Margin Up
BDX's overall topline in the first quarter of fiscal 2025 continues to benefit from revenue growth in all segments.
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors
Becton Dickinson & Co. closed 9.83% short of its 52-week high of $251.99, which the company reached on February 3rd.
Becton, Dickinson and Company (BDX) Q1 2025 Earnings Call Transcript
At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...
Becton Dickinson to Separate Biosciences and Diagnostic Solutions Business
BD plans to separate its Biosciences and Diagnostic Solutions unit into an independent company by fiscal 2026.
Becton Dickinson to separate biosciences, diagnostic solutions business
BD announced its board of directors has unanimously authorized BD management to pursue a plan to separate BD’s Biosciences and Diagnostic ...